Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...
A new federally funded research effort in Rochester is aiming to tackle one of the biggest gaps in treating age-related macular degeneration — stopping vision loss before it starts. Researchers at ...
BrightFocus Foundation today announced $15.2 million in new research grants for Alzheimer’s disease, macular degeneration, and glaucoma, reinforcing its commitment to advancing scientific discovery ...
VLTR-559 demonstrates sustained anti-VEGF activity and favorable safety at target clinical dosefor treatment of wetage-related macular ...
According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel therapeutics across multiple therapeutic areas, announced positive results ...
There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it happens when small deposits form under the retina, causing cells in the ...
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research CLARKSBURG, Md.--(BUSINESS WIRE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results